Ellsworth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.1M Sell
49,045
-1,093
-2% -$255K 1.99% 7
2026
Q1
$12.3M Buy
50,138
+947
+2% +$221K 2.3% 5
2025
Q4
$10.8M Buy
49,191
+1,618
+3% +$320K 2.13% 7
2025
Q3
$9.09M Buy
47,573
+1,461
+3% +$250K 1.94% 8
2025
Q2
$7.04M Buy
46,112
+1,495
+3% +$230K 1.71% 9
2025
Q1
$7.4M Buy
44,617
+1,450
+3% +$227K 1.94% 5
2024
Q4
$6.24M Buy
43,167
+2,058
+5% +$319K 1.64% 10
2024
Q3
$6.66M Buy
41,109
+29,329
+249% +$4.67M 1.73% 9
2024
Q2
$1.72M Buy
11,780
+343
+3% +$51K 0.48% 61
2024
Q1
$1.69M Buy
11,437
+452
+4% +$71.9K 0.48% 60
2023
Q4
$1.72M Buy
10,985
+412
+4% +$63.2K 0.54% 57
2023
Q3
$1.61M Sell
10,573
-38
-0.4% -$6.27K 0.57% 57
2023
Q2
$1.76M Sell
10,611
-96
-0.9% -$15.5K 0.61% 60
2023
Q1
$1.66M Buy
10,707
+75
+0.7% +$12.1K 0.58% 61
2022
Q4
$1.8M Buy
10,632
+964
+10% +$166K 0.68% 58
2022
Q3
$1.58M Buy
9,668
+44
+0.5% +$7.45K 0.68% 56
2022
Q2
$1.71M Sell
9,624
-86
-0.9% -$15.3K 0.69% 53
2022
Q1
$1.79M Buy
9,710
+162
+2% +$27.6K 0.63% 58
2021
Q4
$1.63M Sell
9,548
-81
-0.8% -$13.3K 0.6% 59
2021
Q3
$1.55M Buy
9,629
+169
+2% +$28.8K 0.71% 53
2021
Q2
$1.56M Buy
9,460
+352
+4% +$58.3K 0.76% 56
2021
Q1
$1.5M Buy
9,108
+390
+4% +$63.1K 0.9% 45
2020
Q4
$1.37M Buy
8,718
+1,034
+13% +$153K 0.99% 39
2020
Q3
$1.14M Buy
7,684
+38
+0.5% +$5.62K 1.14% 39
2020
Q2
$1.07M Buy
+7,646
New +$1.11M 1.18% 37

Other funds holding JNJ

Ellsworth Advisors's JNJ Position: Q2 2026 in Review

Ellsworth Advisors reduced its Johnson & Johnson (JNJ) stake by 2.2% in Q2 2026, selling an estimated $255K and leaving 49,045 shares worth $12.1M. The position accounts for 1.99% of the portfolio, ranked #7.

Ellsworth Advisors first reported a position in JNJ in Q2 2020 and has held it in 25 quarters since. The position peaked at $12.3M in Q1 2026. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ellsworth Advisors held 49,045 shares of Johnson & Johnson worth $12.1M as of Q2 2026.
  • Ellsworth Advisors sold 1,093 Johnson & Johnson shares in Q2 2026, an estimated $255K.
  • Johnson & Johnson made up 1.99% of Ellsworth Advisors's portfolio in Q2 2026, its #7 holding.
  • Ellsworth Advisors first reported a position in Johnson & Johnson in Q2 2020 and has held it in 25 quarters since.
  • Ellsworth Advisors's Johnson & Johnson position peaked at $12.3M in Q1 2026.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ellsworth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.